Daniel Spasic has worked in the pharmaceutical and biotechnology industries for over 25 years. Daniel is currently a Board Member at Avance Clinical. Prior to joining Avance Clinical, they were the Executive Chairman at Trialbee and a Non-executive Board Member at Trialbee. Daniel has also worked at Scantox, Proteros biostructures GmbH, Inhalation Sciences Sweden AB, NuvoAir, and Tridentify AB.
Daniel Spasic has an extensive educational career. Daniel has a degree in Owner/President Management Program 54 from Harvard Business School. Daniel also has a degree in Parachute Regiment Swedish Army from the Swedish Armed Forces. Finally, they have a degree in Engineering Chemistry from Tycho Brahe.